Last Updated: August 9, 2026

Litigation Details for Loggerhead Tools, LLC v. Sears Holdings Corporation (N.D. Ill. 2012)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Loggerhead Tools, LLC v. Sears Holdings Corporation
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: Loggerhead Tools, LLC v. Sears Holdings Corporation (N.D. Ill. 2012)

Last updated: June 25, 2026

Loggerhead Tools, LLC v. Sears Holdings Corporation (1:12-cv-09033): Litigation Summary, Claims, Timeline, and IP Risk for Competitors

Executive summary: Loggerhead Tools, LLC sued Sears Holdings Corporation in the Northern District of Illinois under case 1:12-cv-09033. The dispute concerns IP tied to Loggerhead’s products and alleges infringement by Sears’ related tool listings and/or sourcing. The docket for 1:12-cv-09033 is required to produce a complete, clause-level litigation summary (asserted patents or copyrights, claim construction, dispositive rulings, and final judgment). Without docket and merits documents, a complete, accurate litigation analysis cannot be produced.

What claims did Loggerhead Tools assert against Sears in 1:12-cv-09033?

Answer (required for accuracy): Not provided.

Which IP rights were asserted (patents, copyrights, trade dress, or trademark)?

Not provided.

Which product SKUs or accused acts were identified?

Not provided.

What remedies were sought (injunction, damages, fees)?

Not provided.

How did the case progress procedurally in Loggerhead Tools v. Sears (1:12-cv-09033)?

Answer (required for accuracy): Not provided.

Filing, service, and initial pleadings

Not provided.

Motions to dismiss and jurisdictional positions

Not provided.

Markman or claim construction activity

Not provided.

Discovery scope (interrogatories, RFPs, depositions, inspections)

Not provided.

Dispositive motion outcomes

Not provided.

Final disposition (dismissal, settlement, judgment, or consent decree)

Not provided.

When did key litigation deadlines occur in 1:12-cv-09033 (trial, summary judgment, settlement)?

Answer (required for accuracy): Not provided.

Timeline with dates for major docket events

Not provided.

What did the court hold on infringement, validity, and enforceability in 1:12-cv-09033?

Answer (required for accuracy): Not provided.

Infringement analysis

Not provided.

Validity defenses (anticipation, obviousness, written description/enablement, indefiniteness)

Not provided.

Enforceability defenses (inequitable conduct, prosecution history)

Not provided.

Damages methodology (reasonable royalty vs. lost profits)

Not provided.

Did Sears challenge patents/copyrights under specific defenses in Loggerhead Tools v. Sears?

Answer (required for accuracy): Not provided.

Non-infringement theories

Not provided.

Statutory exclusions or indirect infringement theories

Not provided.

How strong was Loggerhead’s asserted IP estate in the context of 1:12-cv-09033?

Answer (required for accuracy): Not provided.

Claim coverage breadth and dependency structure

Not provided.

Prior art exposure and litigation posture

Not provided.

Technology overlap with common tool design features

Not provided.

What settlement terms or licensing outcomes occurred in 1:12-cv-09033?

Answer (required for accuracy): Not provided.

Was there an injunction or “carve-out” for product lines?

Not provided.

Were there royalty, covenant-not-to-sue, or cross-licenses?

Not provided.

How does the outcome of 1:12-cv-09033 affect generic or retail supply chain risk?

Answer (required for accuracy): Not provided.

Risk to competing tool sellers and private-label manufacturers

Not provided.

Risk to retailers’ product assortment and vendor onboarding

Not provided.

What is the IP enforcement posture after Loggerhead Tools v. Sears (1:12-cv-09033)?

Answer (required for accuracy): Not provided.

Ongoing related litigations or continuation actions

Not provided.

Refiled or amended claims

Not provided.

Key Takeaways

  • 1:12-cv-09033 litigation summary cannot be completed without the docket record and merits documents identifying the asserted IP, accused Sears products, procedural rulings, and the case outcome.
  • A data-grade analysis for enforcement strength, settlement posture, and competitor risk requires the exact claims and disposition.

FAQs

  1. What patents or copyrights were asserted in Loggerhead Tools v. Sears (1:12-cv-09033)?
  2. What was the court’s dispositive ruling (dismissal, summary judgment, trial verdict) in 1:12-cv-09033?
  3. Did Sears raise invalidity defenses such as anticipation or obviousness in 1:12-cv-09033?
  4. Were there settlement terms like a covenant-not-to-sue or product redesign obligations?
  5. Did the case result in any injunction affecting tool listings sold through Sears channels?

References (APA)

  1. Not provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.